Comparative Evaluation of SMAD-2 Expression in Oral Submucous Fibrosis and Reactive Oral Lesions.


Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
01 Feb 2020
Historique:
received: 30 06 2019
entrez: 28 2 2020
pubmed: 28 2 2020
medline: 25 11 2020
Statut: epublish

Résumé

The event of fibrosis encompasses involvement of definite immunological and molecular mechanisms. As quite a lot of pro-fibrotic pathways are concerned, a multipronged approach is obligatory to cognize the fibrotic events. SMAD signaling pathway hasn't been studied oral fibrotic events.In the progression of cramming the SMAD signaling pathway in OSMF, the first initiator protein of the pathway was considered for evaluation in the present study. A total of 100 subjects consisting of 20 controls, 40 patients with reactive lesions such as Traumatic Fibroma, Epulis Fissuratum and Gingival Hyperplasia and 40 patients with Oral Submucous Fibrosis were recruited for the study. Tissue homogenates were assayed by quantitative sandwich enzyme immunoassay technique using Human Mothers Against Decapentaplegic Homolog 2 (Smad2). SMAD 2 expression values showed significant difference between control and OSMF group. However, the difference between reactive lesions with control and OSMF were not statistically significant. Graded increase of SMAD 2 expression from control,reactive lesions and OSMF were observed accentuating the role of SMAD signalling pathway in fibro genesis. Further this can be validated to generate effective antifibrotic targets.

Sections du résumé

BACKGROUND BACKGROUND
The event of fibrosis encompasses involvement of definite immunological and molecular mechanisms. As quite a lot of pro-fibrotic pathways are concerned, a multipronged approach is obligatory to cognize the fibrotic events. SMAD signaling pathway hasn't been studied oral fibrotic events.In the progression of cramming the SMAD signaling pathway in OSMF, the first initiator protein of the pathway was considered for evaluation in the present study.
MATERIALS AND METHODS METHODS
A total of 100 subjects consisting of 20 controls, 40 patients with reactive lesions such as Traumatic Fibroma, Epulis Fissuratum and Gingival Hyperplasia and 40 patients with Oral Submucous Fibrosis were recruited for the study. Tissue homogenates were assayed by quantitative sandwich enzyme immunoassay technique using Human Mothers Against Decapentaplegic Homolog 2 (Smad2).
RESULTS RESULTS
SMAD 2 expression values showed significant difference between control and OSMF group. However, the difference between reactive lesions with control and OSMF were not statistically significant.
CONCLUSION CONCLUSIONS
Graded increase of SMAD 2 expression from control,reactive lesions and OSMF were observed accentuating the role of SMAD signalling pathway in fibro genesis. Further this can be validated to generate effective antifibrotic targets.

Identifiants

pubmed: 32102517
doi: 10.31557/APJCP.2020.21.2.399
pmc: PMC7332118
pii:
doi:

Substances chimiques

Biomarkers 0
SMAD2 protein, human 0
Smad2 Protein 0

Types de publication

Comparative Study Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

399-403

Références

Arthritis Rheum. 2008 Aug;58(8):2219-24
pubmed: 18668575
Nat Rev Mol Cell Biol. 2007 Dec;8(12):970-82
pubmed: 18000526
PLoS One. 2012;7(12):e51806
pubmed: 23284772
Nat Cell Biol. 1999 Dec;1(8):472-8
pubmed: 10587642
Acta Biochim Biophys Sin (Shanghai). 2018 Jan 1;50(1):12-36
pubmed: 29293886
Oncol Rep. 2003 Sep-Oct;10(5):1539-44
pubmed: 12883738
Zhonghua Kou Qiang Yi Xue Za Zhi. 2011 Aug;46(8):494-7
pubmed: 22169748
J Pathol. 2011 Feb;223(3):366-77
pubmed: 21171082
Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Aug;122(2):192-9
pubmed: 27289264
Front Pharmacol. 2014 May 27;5:123
pubmed: 24904424
J Oral Pathol Med. 2005 Jul;34(6):321-8
pubmed: 15946178
Trends Immunol. 2010 Mar;31(3):110-9
pubmed: 20106721

Auteurs

Sravya Zagabathina (S)

Department of Oral Pathology and Microbiology, SRM Dental College, SRM University, Chennai, India.

Ramya Ramadoss (R)

Department of Oral Pathology and Microbiology, SRM Dental College, SRM University, Chennai, India.

Harini Priya Ah (HP)

Department of Oral Pathology, Chettinad Dental College and Research Institute, Chennai, India.

Rajkumar Krishnan (R)

Department of Oral Pathology and Microbiology, SRM Dental College, SRM University, Chennai, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH